Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

Using high-resolution peripheral computed tomography (HR-pQCT), we prospectively investigated whether long-term PPI use was associated with changes in volumetric bone mineral densities, bone microarchitecture, and strength in older patients. 189 patients aged ≥ 60 years (n = 24 persistent PPI users [p-PPI user], and n = 165 non-PPI users), enrolled as part of a 2-year vitamin D RCT, underwent HR-pQCT scanning of the tibia and radius at 0 and 2 years.

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Randomised controlled trial.

Randomised controlled trial

Assigns participants or groups to comparison interventions by chance.

Meta-analysis unclear · Double-blind reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

This study used data acquired in the Zurich Multiple Endpoint Vitamin D Trial (): a two-year, double-blind, randomized-controlled trial (RCT) aimed primarily at investigating the effect of two different daily doses of Vitamin D (a standard daily vitamin D dose of 800 IU and a high daily vitamin D dose of 2000 IU) on knee pain and functional performance in 273 patients, ≥ 60 years, who had undergone unilateral total knee replacement due to severe osteoarthritis [].

Source: Methods.

This study used data acquired in the Zurich Multiple Endpoint Vitamin D Trial (): a two-year, double-blind, randomized-controlled trial (RCT) aimed primarily at investigating the effect of two different daily doses of Vitamin D (a standard daily vitamin D dose of 800 IU and a high daily vitamin D dose of 2000 IU) on knee pain and functional performance in 273 patients, ≥ 60 years, who had undergone unilateral total knee replacement due to severe osteoarthritis [].

Source: Methods.

In brief, patients were eligible if they were men or women aged 60 years or more and scheduled for unilateral total knee replacement due to severe knee OA and had no plans for bilateral knee replacement within the next 2 years.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Regular Proton-Pump Inhibitor Intake is Associated with Deterioration of Peripheral Bone Mineral Density, Microarchitecture, and Strength in Older Patients as Assessed by High-Resolution Peripheral Quantitative Computed Tomography (HR-pQCT)

Randomised controlled trial · Calcified Tissue International · 2025

Original publication title

Regular Proton-Pump Inhibitor Intake is Associated with Deterioration of Peripheral Bone Mineral Density, Microarchitecture, and Strength in Older Patients as Assessed by High-Resolution Peripheral Quantitative Computed Tomography (HR-pQCT)

Ursula Heilmeier; Alexandra Siegenthaler; Ursina Meyer; Marie Boensch; Melanie Kistler-Fischbacher; Caroline de Godoi Rezende Costa Molino; Bert van Rietbergen; Wei Lang; René Rizzoli; Robert Theiler; Andreas Egli; Heike Annette Bischoff-Ferrari

© The Author(s) 2025

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

Proton-pump inhibitors (PPI) are widely used among older adults and PPI intake has been associated with increased fracture risk. However, their association with bone microarchitecture and strength remains unclear as prior clinical PPI studies were restricted to lower-resolution bone imaging techniques such as DXA. Using high-resolution peripheral computed tomography (HR-pQCT), we prospectively investigated whether long-term PPI use was associated with changes in volumetric bone mineral densities, bone microarchitecture, and strength in older patients. 189 patients aged ≥ 60 years (n = 24 persistent PPI users [p-PPI user], and n = 165 non-PPI users), enrolled as part of a 2-year vitamin D RCT, underwent HR-pQCT scanning of the tibia and radius at 0 and 2 years.

Bone volumetric density (vBMD), microarchitectural and strength parameters were computed and adjusted linear regression models without and with adjustments, including age, sex, BMI, and treatment groups, were employed to compare changes between p-PPI users and non-PPI users. At baseline, both groups were comparable with respect to age, vBMDs, bone microarchitecture, and sex. During follow-up, p-PPI users lost significantly more distal tibial total volumetric BMD (ΔTt.BMD: − 8.58 vs. − 2.45 mg/cm3, p = 0.012) and cortical volumetric BMD (ΔCt.BMD, − 28.96 vs. -14.07 mg/cm3, p = 0.005), and showed a significantly greater loss in tibial bone strength (Δstiffness − 4848.1 vs. 20.7 N/mm, p = 0.029; Δfailure load − 204.5 vs. 16.7 N, p = 0.026) than non-PPI users.

At the radius, p-PPI users showed over the 2 years significantly greater increases in cortical porosity and intracortical pore diameter than non-PPI users (ΔCt.Po, p = 0.005; ΔCt.PoDm, p = 0.009). Long-term PPI intake was associated with a significant decline in cortical microarchitecture at the radius and with a significant deterioration of volumetric bone mineral density and strength at the tibia in older patients.

Supplementary Information

The online version contains supplementary material available at 10.1007/s00223-025-01420-7.

Authors’ abstract

Proton-pump inhibitors (PPI) are widely used among older adults and PPI intake has been associated with increased fracture risk. However, their association with bone microarchitecture and strength remains unclear as prior clinical PPI studies were restricted to lower-resolution bone imaging techniques such as DXA. Using high-resolution peripheral computed tomography (HR-pQCT), we prospectively investigated whether long-term PPI use was associated with changes in volumetric bone mineral densities, bone microarchitecture, and strength in older patients. 189 patients aged ≥ 60 years (n = 24 persistent PPI users [p-PPI user], and n = 165 non-PPI users), enrolled as part of a 2-year vitamin D RCT, underwent HR-pQCT scanning of the tibia and radius at 0 and 2 years.

Bone volumetric density (vBMD), microarchitectural and strength parameters were computed and adjusted linear regression models without and with adjustments, including age, sex, BMI, and treatment groups, were employed to compare changes between p-PPI users and non-PPI users. At baseline, both groups were comparable with respect to age, vBMDs, bone microarchitecture, and sex. During follow-up, p-PPI users lost significantly more distal tibial total volumetric BMD (ΔTt.BMD: − 8.58 vs. − 2.45 mg/cm3, p = 0.012) and cortical volumetric BMD (ΔCt.BMD, − 28.96 vs. -14.07 mg/cm3, p = 0.005), and showed a significantly greater loss in tibial bone strength (Δstiffness − 4848.1 vs. 20.7 N/mm, p = 0.029; Δfailure load − 204.5 vs. 16.7 N, p = 0.026) than non-PPI users.

At the radius, p-PPI users showed over the 2 years significantly greater increases in cortical porosity and intracortical pore diameter than non-PPI users (ΔCt.Po, p = 0.005; ΔCt.PoDm, p = 0.009). Long-term PPI intake was associated with a significant decline in cortical microarchitecture at the radius and with a significant deterioration of volumetric bone mineral density and strength at the tibia in older patients.

Supplementary Information

The online version contains supplementary material available at 10.1007/s00223-025-01420-7.

Publication and source details

Original title: Regular Proton-Pump Inhibitor Intake is Associated with Deterioration of Peripheral Bone Mineral Density, Microarchitecture, and Strength in Older Patients as Assessed by High-Resolution Peripheral Quantitative Computed Tomography (HR-pQCT)

Ursula Heilmeier; Alexandra Siegenthaler; Ursina Meyer; Marie Boensch; Melanie Kistler-Fischbacher; Caroline de Godoi Rezende Costa Molino; Bert van Rietbergen; Wei Lang; René Rizzoli; Robert Theiler; Andreas Egli; Heike Annette Bischoff-Ferrari

Calcified Tissue International · 2025

© The Author(s) 20252025https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.http://dx.doi.org/10.13039/501100001711Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen ForschungPP00B-114864Bischoff-Ferrari Heike Annette http://dx.doi.org/10.13039/100007214Velux Stiftung441Bischoff-Ferrari Heike Annette http://dx.doi.org/10.13039/501100007252Baugarten StiftungECTS Academy Personal Reserach GrantUniversity of Zurich

Open access funding provided by University of Zurich

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T00:56:22.759562+00:00

DOI: 10.1007/s00223-025-01420-7 · PMC12546302